Treatment Patterns Among Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Receiving Secondand Third-Line Therapy in a Medicare Population

被引：0
|
作者：
Tkacz, Joseph [1 ]
Gorsh, Boris [2 ]
Molinari, Alexa [2 ]
Boytsov, Natalie [2 ]
Wang, Peter Feng [2 ]
Perera, Sue [3 ]
Landi, Suzanne [2 ]
Hanna, Maya [2 ]
Johnson, William [1 ]
Schroeder, Amy [1 ]
Paka, Prani [2 ]
机构：
[1] Inovalon, Bowie, MD USA
[2] GlaxoSmithKline, Providence, RI USA
[3] GlaxoSmithKline, London, England
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2022年 / 22卷
关键词：
MM; relapsed/refractory multiple myeloma; treatment; patterns; drug classes; Medicare; retreatment;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MM-451
引用
收藏
页码：S423 / S423
页数：1
相关论文
共 50 条
  • [1] Treatment patterns among patients with relapsed/refractory multiple myeloma (RRMM) in Taiwan
    Huang, Jeffrey Shang-Yi
    Wang, Ming-Chung
    Yeh, Su-Peng
    Chen, Tsai-Yun
    Teng, Chieh-Lin Jerry
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S188 - S189
  • [2] Real-World Treatment Patterns of Patients Initiating Third-Line Therapy in Relapsed or Refractory Multiple Myeloma in Europe
    Lehne, Moritz
    Kortuem, K. Martin
    Zamagni, Elena
    d'Estrube, Tim
    Shukla, Soham
    Zhuleku, Evi
    Ghiani, Marco
    Hanna, Maya
    Maywald, Ulf
    Wilke, Thomas
    Perera, Sue
    [J]. BLOOD, 2022, 140 : 12485 - 12486
  • [3] Standards of Care and Treatment Patterns Among Relapsed/Refractory Multiple Myeloma Patients Initiating Second- and Third-Line Therapies
    Boytsov, Natalie
    Gorsh, Boris
    Anderson, Seth
    Wang, Peter Feng
    Perera, Sue
    Franklin, Meg
    [J]. BLOOD, 2022, 140 : 12554 - 12555
  • [4] Treatment Patterns and Outcomes Among Patients Who Initiate Therapy for Relapsed/Refractory Multiple Myeloma (RRMM) in Routine Care
    Romanus, Dorothy
    Jhaveri, Mehul
    Labotka, Richard
    Henk, Henry
    Seal, Brian
    [J]. BLOOD, 2015, 126 (23)
  • [5] Therapy of relapsed and/or refractory multiple myeloma (RRMM)
    Engelhardt, M.
    Waesch, R.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 14 - 14
  • [6] Patient Characteristics, Treatment Patterns and Outcomes Among Relapsed/Refractory Multiple Myeloma (RRMM) Patients in Japan
    Jun, Gyungjin
    Luptakova, Katarina
    Koizumi, Hiroo
    Iwasaki, Kosuke
    Hiroi, Shinzo
    Soeda, Junpei
    [J]. BLOOD, 2016, 128 (22)
  • [7] Selinexor for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma (RRMM)
    Anum, Babar
    Hina, Zubair
    Mainoma, Bano
    Sana, Rafique
    Arzu, Shahid
    Maham, Babar
    Waleed, Madeeha S.
    Arslan, Inayat
    Danish, Safi
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 : S29 - S29
  • [8] Prospective longitudinal study on quality of life in relapsed/refractory multiple myeloma patients receiving second- or third-line lenalidomide or bortezomib treatment
    Leleu, X.
    Kyriakou, C.
    Broek, Vande
    Murphy, P.
    Bacon, P.
    Lewis, P.
    Gilet, H.
    Arnould, B.
    Petrucci, M. T.
    [J]. BLOOD CANCER JOURNAL, 2017, 7 : e543 - e543
  • [9] Prospective longitudinal study on quality of life in relapsed/refractory multiple myeloma patients receiving second- or third-line lenalidomide or bortezomib treatment
    X Leleu
    C Kyriakou
    I Vande Broek
    P Murphy
    P Bacon
    P Lewis
    H Gilet
    B Arnould
    M T Petrucci
    [J]. Blood Cancer Journal, 2017, 7 : e543 - e543
  • [10] Predictors of Second-Line Treatment Choice with Triplet Therapy in Routine Care Among Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
    Romanus, Dorothy
    Jhaveri, Mehul
    Labotka, Richard
    Henk, Henry
    Seal, Brian
    [J]. BLOOD, 2015, 126 (23)
12345